Septerna (SEPN) Current Deferred Tax Assets (2023 - 2025)

Septerna's quarterly Current Deferred Tax Assets came in at $39000.0 in Q2 2025, little changed quarter-over-quarter from $39000.0 in Q1 2025.

Septerna has reported Current Deferred Tax Assets for 3 years, with the latest figure at $39000.0 in Q2 2025.

  • For the quarter ending Q2 2025, Current Deferred Tax Assets changed N/A year-over-year to $39000.0; the trailing twelve-month figure through Jun 2025 stood at $39000.0 (changed N/A YoY), and the FY2024 full-year result was $39000.0, down 48.0% from the prior year.
  • Current Deferred Tax Assets for Q2 2025 stood at $39000.0, roughly flat from $39000.0 in the prior quarter.
  • The five-year high for Current Deferred Tax Assets was $232000.0 in Q3 2024, with the low at $39000.0 in Q4 2024.
  • Average Current Deferred Tax Assets over 3 years is $84800.0, with a median of $39000.0 recorded in 2024.
  • Peak annual rise in Current Deferred Tax Assets reached 48.0% in 2024, while the deepest fall reached 48.0% in 2024.
  • Tracing SEPN's Current Deferred Tax Assets over 3 years: stood at $75000.0 in 2023, then sank by 48.0% to $39000.0 in 2024, then changed by 0.0% to $39000.0 in 2025.
  • The last three Current Deferred Tax Assets figures came in at $39000.0 (Q2 2025), $39000.0 (Q1 2025), and $39000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Septerna 1.34 Bn 1.34 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 39,000.00
Jun 30, 2025 39,000.00
Mar 31, 2025 39,000.00
Mar 31, 2025 39,000.00
Dec 31, 2024 39,000.00
Dec 31, 2024 39,000.00
Sep 30, 2024 232,000.00
Sep 30, 2024 232,000.00
Dec 31, 2023 75,000.00
Dec 31, 2023 75,000.00